Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/124740
Title: Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact : the ASPERA-R study
Author(s): Santis, Federico
Barba, LorenzoLook up in the Integrated Authority File of the German National Library
Musienko, ViktoriaLook up in the Integrated Authority File of the German National Library
Otto, MarkusLook up in the Integrated Authority File of the German National Library
[und viele weitere]
Issue Date: 2026
Type: Article
Language: English
Abstract: Background Oral anticoagulants (OACs), including vitamin K antagonists and direct OACs, reduce stroke risk in atrial fibrillation (AF), yet breakthrough ischemic stroke still occurs in 1–2% of patients annually despite adequate therapy. The mechanisms underlying these events remain unclear. We aimed to identify potential causes of breakthrough ischemic stroke and assess their impact on outcomes, with a focus on drug interactions. Methods ASPERA-R is a multicenter retrospective study including patients with ischemic stroke despite ongoing OAC therapy for AF (February 2020–February 2025). Ongoing treatment was defined by DOAC last intake within 48 h or therapeutic INR levels for VKAs. Potential causes included interacting drugs, active cancer, and competing etiologies. Ninety-day outcomes were compared between patients with and without ≥ 1 potential cause using adjusted Cox regression. Inverse probability-weighted analyses (IPW) evaluated the impact of interacting drugs. Results Among 1649 patients (median age 80.4 years [IQR 73.2–85.6]; 860 [52.2%] female), most were on DOACs (1275; 77.3%), and 724 (43.9%) had ≥ 1 potential cause. Interacting drugs were identified in 28.4%, competing etiologies in 24.3%, and cancer in 4.4% cases. Patients with one or more potential cause had a higher risk of recurrent ischemic stroke at 90 days (HR 2.04, 95% CI 1.18–3.53) compared with those without, with no differences in other outcomes. In the IPW analyses, interacting drugs were associated with increased myocardial infarction risk (HR 3.26, 95% CI 1.30–8.17). Conclusions Potential causes are identifiable in about half of breakthrough strokes and are associated with higher risk of recurrence compared with those without. Improved detection and management of these factors may reduce recurrence risk, warranting individualized approaches.
URI: https://opendata.uni-halle.de//handle/1981185920/126674
http://dx.doi.org/10.25673/124740
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Journal Title: Journal of neurology
Publisher: Steinkopff
Publisher Place: [Darmstadt]
Volume: 273
Original Publication: 10.1007/s00415-026-14039-x
Page Start: 1
Page End: 21
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s00415-026-14039-x.pdf1.06 MBAdobe PDFThumbnail
View/Open